BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2369 related articles for article (PubMed ID: 8181865)

  • 1. The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor-infiltrating lymphocytes.
    Lüscher U; Filgueira L; Juretic A; Zuber M; Lüscher NJ; Heberer M; Spagnoli GC
    Int J Cancer; 1994 May; 57(4):612-9. PubMed ID: 8181865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of interleukin-2 and CD3 triggering on cytokine gene transcription and secretion in cultured tumor infiltrating lymphocytes.
    Filgueira L; Zuber M; Juretic A; Lüscher U; Caetano V; Harder F; Garotta G; Heberer M; Spagnoli GC
    Cell Immunol; 1993 Aug; 150(1):205-18. PubMed ID: 8343966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide-specific CTL in tumor infiltrating lymphocytes from metastatic melanomas expressing MART-1/Melan-A, gp100 and Tyrosinase genes: a study in an unselected group of HLA-A2.1-positive patients.
    Spagnoli GC; Schaefer C; Willimann TE; Kocher T; Amoroso A; Juretic A; Zuber M; Luscher U; Harder F; Heberer M
    Int J Cancer; 1995 Oct; 64(5):309-15. PubMed ID: 7591302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tumor-immune system interaction in renal cell carcinoma and melanomas. Cytokine transcription in tumors at the time of surgical resection].
    Zuber M; Filgueira L; Merlo A; Lüscher U; Juretic A; Spagnoli G; Harder F; Heberer M
    Schweiz Med Wochenschr; 1994 Jun; 124(22):930-5. PubMed ID: 8029672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes.
    Wang Q; Redovan C; Tubbs R; Olencki T; Klein E; Kudoh S; Finke J; Bukowski RM
    Int J Cancer; 1995 Jun; 61(6):780-5. PubMed ID: 7790111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sub-sets of CD4+ and CD8+ cytotoxic T-cell clones directed to autologous human melanoma identified by cytokine profiles.
    Maccalli C; Mortarini R; Parmiani G; Anichini A
    Int J Cancer; 1994 Apr; 57(1):56-62. PubMed ID: 7908659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with gamma-interferon genes.
    Ogasawara M; Rosenberg SA
    Cancer Res; 1993 Aug; 53(15):3561-8. PubMed ID: 8101762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and molecular characterization of tumour-infiltrating lymphocytes and clones thereof from a major-histocompatibility-complex-negative human tumour: neuroblastoma.
    Facchetti P; Prigione I; Ghiotto F; Tasso P; Garaventa A; Pistoia V
    Cancer Immunol Immunother; 1996 Mar; 42(3):170-8. PubMed ID: 8640845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usage of T-cell receptor V beta chain genes in fresh and cultured tumor-infiltrating lymphocytes from human melanoma.
    Weidmann E; Elder EM; Trucco M; Lotze MT; Whiteside TL
    Int J Cancer; 1993 May; 54(3):383-90. PubMed ID: 8509212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine gene expression in primary brain tumours, metastases and meningiomas suggests specific transcription patterns.
    Merlo A; Juretic A; Zuber M; Filgueira L; Lüscher U; Caetano V; Ulrich J; Gratzl O; Heberer M; Spagnoli GC
    Eur J Cancer; 1993; 29A(15):2118-25. PubMed ID: 8297651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
    Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A
    J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of autologous tumor-specific T-helper 2 cells in tumor-infiltrating lymphocytes from a patient with metastatic melanoma.
    Kharkevitch DD; Seito D; Balch GC; Maeda T; Balch CM; Itoh K
    Int J Cancer; 1994 Aug; 58(3):317-23. PubMed ID: 7914181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines.
    Nash MA; Lenzi R; Edwards CL; Kavanagh JJ; Kudelka AP; Verschraegen CF; Platsoucas CD; Freedman RS
    Clin Exp Immunol; 1998 May; 112(2):172-80. PubMed ID: 9649178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective lymphokine production by most CD8+ and CD4+ tumor-specific T cell clones derived from human melanoma-infiltrating lymphocytes in response to autologous tumor cells in vitro.
    Guilloux Y; Viret C; Gervois N; Le Dréan E; Pandolfino MC; Diez E; Jotereau F
    Eur J Immunol; 1994 Sep; 24(9):1966-73. PubMed ID: 7522155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
    Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
    Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing infiltration and activation of CD8+ tumor-infiltrating lymphocytes after eliminating immune suppressive granulocyte/macrophage progenitor cells with low doses of interferon gamma plus tumor necrosis factor alpha.
    Young MR; McCloskey G; Wright MA; Pak AS
    Cancer Immunol Immunother; 1994 Jan; 38(1):9-15. PubMed ID: 8299123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphokine production by human melanoma tumor-infiltrating lymphocytes.
    Salmeron MA; Morita T; Seki H; Platsoucas CD; Itoh K
    Cancer Immunol Immunother; 1992; 35(3):211-7. PubMed ID: 1386286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the activation status of tumor infiltrating and peripheral lymphocytes of patients with adenocarcinomas and benign hyperplasia of the prostate.
    Elsässer-Beile U; Przytulski B; Gierschner D; Grussenmeyer T; Katzenwadel A; Leiber C; Deckart A; Wetterauer U
    Prostate; 2000 Sep; 45(1):1-7. PubMed ID: 10960837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered CD3 chain and cytokine gene expression in tumor infiltrating T lymphocytes during the development of mesothelioma.
    Jarnicki AG; Fitzpatrick DR; Robinson BW; Bielefeldt-Ohmann H
    Cancer Lett; 1996 May; 103(1):1-9. PubMed ID: 8616801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of cytokine mRNA expression in tumour-infiltrating mononuclear cells and tumour cells freshly isolated from human colorectal carcinomas.
    Csiszár A; Szentes T; Haraszti B; Zou W; Emilie D; Petrányi G; Pócsik E
    Eur Cytokine Netw; 2001 Mar; 12(1):87-96. PubMed ID: 11282551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 119.